Cargando…
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
OBJECTIVE: Studies examining differences in US healthcare resource utilization (HCRU) and associated healthcare costs between collagenase clostridium histolyticum (CCH) and fasciectomy for Dupuytren contracture (DC) are limited. This study evaluated US HCRU and direct healthcare cost for the treatme...
Autores principales: | Zah, Vladimir, Pelivanovic, Jovana, Tatovic, Simona, Vukicevic, Djurdja, Imro, Martina, Ruby, Jane, Hurley, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649243/ https://www.ncbi.nlm.nih.gov/pubmed/33177851 http://dx.doi.org/10.2147/CEOR.S269957 |
Ejemplares similares
-
Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
por: Zah, Vladimir, et al.
Publicado: (2022) -
Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015) -
Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020) -
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis [Corrigendum]
Publicado: (2021) -
Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016
por: Zah, Vladimir, et al.
Publicado: (2019)